Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
Neurochemical Research
|
August 1, 1994
Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: a review
V K Tuohy
Immunology Today
|
April 16, 1998
Gene therapy in the treatment of autoimmune disease
P M Mathisen, V K Tuohy
Research in Immunology
|
January 29, 1999
T-cell design: optimizing the therapeutic potential of autoreactive T cells by genetic modification
V K Tuohy, P M Mathisen
Archivum Immunologiae Et Therapiae Experimentalis
|
January 5, 2001
Epitope spreading: a mechanism for progression of autoimmune disease
V K Tuohy, R P Kinkel
Journal of Clinical Immunology
|
October 29, 2000
Gene therapy in experimental autoimmune encephalomyelitis
P M Mathisen, V K Tuohy
Journal of Neuroimmunology
|
June 16, 2000
T cell design for therapy in autoimmune demyelinating disease
V K Tuohy, P M Mathisen
Archivum Immunologiae Et Therapiae Experimentalis
|
December 4, 2001
Gene therapy for autoimmune demyelinating disease of the central nervous system
P M Mathisen, V K Tuohy
Journal of Neuroimmunology
|
February 1, 1995
Sequence 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice
V K Tuohy, D M Thomas
The Journal of Experimental Medicine
|
April 1, 1996
A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease
M Yu, J M Johnson, V K Tuohy
Journal of Neuroscience Research
|
August 15, 1996
Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis
M Yu, J M Johnson, V K Tuohy
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
Neurochemical Research
|
August 1, 1994
Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: a review
V K Tuohy
Immunology Today
|
April 16, 1998
Gene therapy in the treatment of autoimmune disease
P M Mathisen, V K Tuohy
Research in Immunology
|
January 29, 1999
T-cell design: optimizing the therapeutic potential of autoreactive T cells by genetic modification
V K Tuohy, P M Mathisen
Archivum Immunologiae Et Therapiae Experimentalis
|
January 5, 2001
Epitope spreading: a mechanism for progression of autoimmune disease
V K Tuohy, R P Kinkel
Journal of Clinical Immunology
|
October 29, 2000
Gene therapy in experimental autoimmune encephalomyelitis
P M Mathisen, V K Tuohy
Journal of Neuroimmunology
|
June 16, 2000
T cell design for therapy in autoimmune demyelinating disease
V K Tuohy, P M Mathisen
Archivum Immunologiae Et Therapiae Experimentalis
|
December 4, 2001
Gene therapy for autoimmune demyelinating disease of the central nervous system
P M Mathisen, V K Tuohy
Journal of Neuroimmunology
|
February 1, 1995
Sequence 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice
V K Tuohy, D M Thomas
The Journal of Experimental Medicine
|
April 1, 1996
A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease
M Yu, J M Johnson, V K Tuohy
Journal of Neuroscience Research
|
August 15, 1996
Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis
M Yu, J M Johnson, V K Tuohy
Page
of 6